1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > High-Grade Glioma Global Clinical Trials Review, H1, 2016

High-Grade Glioma Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, “High-Grade Glioma Global Clinical Trials Review, H1, 2016" provides an overview of High-Grade Glioma clinical trials scenario. This report provides top line data relating to the clinical trials on High-Grade Glioma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

High-Grade Glioma Global Clinical Trials Review, H1, 2016
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of High-Grade Glioma to Oncology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of High-Grade Glioma to Oncology Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in High-Grade Glioma Therapeutics Clinical Trials 26
Prominent Drugs 27
Latest Clinical Trials News on High-Grade Glioma 28
May 13, 2016: Tocagen to Present Clinical and Preclinical Data at Three Scientific Meetings 28
May 03, 2016: Tocagen Presents Intravenous Toca 511 Clinical Data at the 84th AANS Annual Scientific Meeting 28
Apr 13, 2016: Tocagen to Present Data from Clinical Trials and Preclinical Programs at Four Scientific Conferences 29
Clinical Trial Profile Snapshots 30
Appendix 194
Abbreviations 194
Definitions 194
Research Methodology 195
Secondary Research 195
About GlobalData 196
Contact Us 196
Disclaimer 196
Source 197

List of Tables
High-Grade Glioma Therapeutics, Global, Clinical Trials by Region, 2016* 6
High-Grade Glioma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
High-Grade Glioma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
High-Grade Glioma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
High-Grade Glioma Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
High-Grade Glioma Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
High-Grade Glioma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12
Proportion of High-Grade Glioma to Oncology Clinical Trials, G7 Countries (%), 2016* 13
High-Grade Glioma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
High-Grade Glioma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of High-Grade Glioma to Oncology Clinical Trials, E7 Countries (%), 2016* 16
High-Grade Glioma Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
High-Grade Glioma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18
High-Grade Glioma Therapeutics, Global, Clinical Trials by Phase, 2016* 19
High-Grade Glioma Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 20
High-Grade Glioma Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
High-Grade Glioma Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
High-Grade Glioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
High-Grade Glioma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 24
High-Grade Glioma Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
High-Grade Glioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26
High-Grade Glioma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 27

List of Figures
High-Grade Glioma Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
High-Grade Glioma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
High-Grade Glioma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
High-Grade Glioma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
High-Grade Glioma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
High-Grade Glioma Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
High-Grade Glioma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12
Proportion of High-Grade Glioma to Oncology Clinical Trials, G7 Countries (%), 2016* 13
High-Grade Glioma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
High-Grade Glioma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of High-Grade Glioma to Oncology Clinical Trials, E7 Countries (%), 2016* 16
High-Grade Glioma Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
High-Grade Glioma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18
High-Grade Glioma Therapeutics, Global, Clinical Trials by Phase (%), 2016* 19
High-Grade Glioma Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 20
High-Grade Glioma Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
High-Grade Glioma Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
High-Grade Glioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
High-Grade Glioma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 24
High-Grade Glioma Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
High-Grade Glioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26
High-Grade Glioma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 27
GlobalData Methodology 195

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

Brain Cancer: Analytical Tool

Brain Cancer: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Glioblastoma Multiforme-Market Insights, Epidemiology and Market Forecast-2023

Glioblastoma Multiforme-Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Glioblastoma Multiforme - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...


Download Unlimited Documents from Trusted Public Sources

Cancer Statistics in the US

  • December 2016
    112 pages
  • Cancer  

  • United States  

    North America  

View report >

Cancer Statistics in the US

  • November 2016
    74 pages
  • Cancer  

  • United States  

View report >

Cancer Statistics and Therapy Market in the US - Forecast

  • November 2016
    52 pages
  • Cancer  

    Therapy  

  • United States  

View report >

Related Market Segments :

Brain Cancer
Clinical Trial
Therapy
Protein

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.